Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
8.3%
% of XLV's 60 holdings also in OZEM
23.8%
% of OZEM's 22 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.4% | 16.9% | 13.4% |
|
AMGEN INC | 3.0% | 3.0% | 3.0% |
|
PFIZER INC | 2.5% | 3.5% | 2.5% |
|
GILEAD SCIENCES INC | 2.6% | 1.8% | 1.8% |
|
REGENERON PHARMACEUTICALS | 1.2% | 2.3% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 8.5% |
|
JOHNSON & JOHNSON | 7.7% |
|
ABBVIE INC | 6.2% |
|
ABBOTT LABORATORIES | 4.6% |
|
MERCK & CO. INC. | 4.0% |
|
INTUITIVE SURGICAL INC | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
DANAHER CORP | 2.4% |
XLV Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -16.2% |
 |
ROCHE HOLDING LTD | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ZEALAND PHARMA A/S | -4.6% |
|
VIKING THERAPEUTICS, INC. | -4.1% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
ALTIMMUNE, INC. | -3.6% |
|
ELI LILLY & CO | -3.5% |
 |
HANMI PHARM CO LTD | -3.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.1% |